In a recent study, a significant relationship was observed between serum OPG levels and risks associated with left ventricular hypertrophy, as well as systolic and diastolic dysfunction, in CKD patients ranging from stage 3 to pre-dialysis 522. Here, TNFRSF11B is linked to left ventricular hypertrophy.